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ABSTRACT

Tight regulation of cephalic blood circulation is critical under normal physiological
conditions, and dysregulation of blood flow to the head occurs in pathophysiological
situations such as stroke and migraine headache. The facial artery is an extracranial artery
which is one of branches from the external carotid artery territory and its extracranial
position indicates its importance in regulating head hemodynamics. Transient receptor
potential vanniloid type 1 (TRPV1) is a cation channel permeable to Ca2+ and Na+.
Intracellular Ca2+ increase causes vasoconstriction. A previous study indicated the
presence of TRPV1 in smooth muscle cells in the facial artery. Protein kinase C (PKC) is
found to sensitize TRPV1 channels in neurons. Our lab’s preliminary data suggested
PKC modulates TRPV1 in the middle meningeal artery. Serotonin (5-HT) is an
endogenous vasoconstrictor, and the 5-HT2 receptor is a Gq-protein-coupled receptor that
activates PKC. In the present study, we found that 5-HT caused facial artery constriction.
Thus, we studied whether TRPV1 channel acting as a Ca2+ entry channel is involved in 5HT induced facial artery constriction. We used a pressurized arteriography technique to
examine the artery diameter. The results indicate that 1) TRPV1 antagonist blunted 30
nM 5-HT-induced mouse facial artery constriction. 5-HT constriction on the facial artery
from TRPV1 knock out mice was significantly blunted compared to the constriction on
the facial artery from wild type mice; 2) PKC, which is a downstream signaling molecule
of 5-HT2 receptor, is involved in capsaicin (TRPV1 agonist)-induced facial artery
constriction; 3) 5-HT-induced facial artery constriction is mediated mostly by activation
of 5-HT1 and 5-HT2 receptors; 4) 5-HT2 but not 5-HT1 receptor is involved in 5-HTinduced facial artery constriction via opening of TRPV1 channels; 5) PKC may be
involved in 5-HT-induced facial artery constriction; 6) The L-type-voltage-dependent
Ca2+ channel is involved in 5-HT-induced facial artery constriction. We conclude that
activation of TRPV1 channel contributes to serotonin-induced 5-HT2 receptor-mediated
constriction of the mouse facial artery.
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CHAPTER 1: LITERATURE REVIEW

1.1 TRPV1 channels

1.1.1 General overview of TRPV1

The TRP family includes seven main subfamilies: TRPA (transient receptor potential
ankyrin), TRPC (transient receptor potential canonical), TRPM (transient receptor
potential melastatin), TRPP (transient receptor potential polycystin), TRPML (transient
receptor potential mucolipin), TRPN (transient receptor potential NOMPC, referred to as
no mechanoreceptor potential C), and TRPV (transient receptor potential vanilloid),
among which TRPN is the only channel not expressed in mammalian cells (Pedersen et
al., 2005). Many TRP channels were detected in vascular smooth muscles including
TRPC (1, 3, 4-6), TRPV (1-4), TRPA1, TRPM4, 8, TRPP2 (Earley and Brayden, 2015).
TRPV1 is a nonselective cation channel, however it exhibits approximately a tenfold
preference for Ca2+ over Na+. TRPV1 has also been shown to mediate the influx of
relatively large cations such as FM1-43, H3O+ ions, tetraethylammonium and NMDG in
response to agonist stimulation (Chung et al., 2008). The TRPV1 channel was first
described in small nociceptive dorsal root ganglion (DRG) and trigeminal ganglion (TG)
neurons. A single clone encoding the TRPV1 channel was first identified in 1997 by Dr.
David Julius’ research group in HEK293 cells transfected with pools of clones from a
rodent dorsal root ganglion (Caterina et al., 1997). TRPV1 has an N-terminal intracellular
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domain containing three ankyrin repeats, six transmembrane (TM) spanning regions
interrupted by a pore loop domain (between TM 5 & 6) and a large C-terminal
intracellular domain (Schumacher and Eilers, 2010). Tyr 511 and Ser 512, located at the
transition between the second intracellular loop and the third TM domain has been
suggested to interact with vanilloid ligands for example capsaicin at the intracellular face
of the membrane (Tominaga and Tominaga, 2005). The distal half of the TRPV1 Cterminus is reportedly involved in the thermal sensitivity of the channel, most evidence
suggesting that TRPV1 is activated by temperatures in the noxious range with an
activation threshold of 43°C (Caterina et al., 1997; Vlachova et al., 2003). It can also be
activated by some endogenous lipid-derived molecules such as lysophosphatidic acid,
amines such as N-acyl-ethanolamines and N-acyl-dopamines, endogenous anandamide,
acidic solutions (pH < 6.5) and some pungent chemicals such as capsaicin, as well as by
toxins such as resiniferatoxin and vanillotoxins (neurotoxins found in the venom of the
tarantula Psalmopoeus cambridgei) (Bevan et al., 2014). In addition to its capsaicin-,
proton-, and temperature-dependent activation, TRPV1 can also be modulated by cell
membrane and intra-cellular components. TRPV1 has been reported to be modulated by
tyrosine kinases or G-protein-coupled receptors (Vellani et al., 2001). After TRPV1
channels are modulated by tyrosine kinases and G-protein-coupled receptors, the channel
opens even at a normal body temperature (Vellani et al., 2001). TRPV1 is also modulated
by protein kinase C (PKC), protein kinase A (PKA), calmodulin (CaM) (Numazaki et al.,
2003), CaMKII (Jung et al., 2004) and Src kinase (Jin et al., 2004). Stimulation of
TRPV1 activity can be achieved through inflammatory agents such as bradykinin,
serotonin, histamine, or prostaglandins, which stimulate TRPV1 either by protein kinase
2

C–dependent pathways (Cesare et al., 1999; Premkumar and Ahern, 2000; Vellani et al.,
2001), by releasing the channel from phosphatidylinositol 4,5-bisphosphate (PIP2)dependent inhibition (Chuang et al., 2001; Prescott and Julius, 2003), by a protein kinase
A–mediated recovery from inactivation (Bhave et al., 2002), or by formation of 12hydroperoxyeicosatetraenoic acid (12-HPETE) (Shin et al., 2002). Phosphorylation by
protein kinase A or protein kinase C reduces the threshold temperature for TRPV1
activation. Specifically, TRPV1 can be phosphorylated at S502A/S800A by PKC, leading
to temperature threshold decrease (Jordt et al., 2000; Numazaki et al., 2002). TRPV1
levels in DRG neurons were increased by nerve growth factor and the activation of p38
mitogen-activated protein kinase in inflamed skin (Chen et al., 2008).

Although TRPV1 is primarily restricted to nociceptors in primary sensory ganglia it has
minimal expression in a few discrete brain regions such as the caudal hypothalamus
(Cavanaugh et al., 2011). This channel is also present in a large portion of neurons of the
nodose and jugular sensory vagal ganglia (Lee and Gu, 2009). Prominent expression of
TRPV1 was found in sensory nerves and arteriolar smooth muscle (ASM) of bladder
(Phan et al., 2016). Measurements of capsaicin-evoked calcium in artery smooth muscle
(ASM) cells and constriction of bladder arterioles suggested TRPV1 has a functional role
in the overactive bladder (Nilius et al., 2007). Capsaicin or resiniferatoxin directly
activated capsaicin-sensitive primary sensory neurons in the sub-epithelial layer of the
bladder. This resulted in release of substance P that sensitized smooth muscle cells
causing increased contractility (Pinna et al., 1994). TRPV1 has also been shown to play a
role in heat hyperalgesia, motor disorders, skin disorders, gastrointestinal tract diseases,
3

airway hypersensitivity, and heart ischemia. Locally applied capsaicin reduced
inflammation-evoked heat hyperalgesia, suggesting that TRPV1 plays an important role
in the development of inflammatory heat hyperalgesia (Coderre et al., 1986). Capsaicin,
through TRPV1 activating cyclooxygenase-2 in a Ca2+-dependent manner, induced the
release of interleukin-8 and prostaglandin E2, which are important signaling molecules
associated with skin disorders (Southall et al., 2003). Within the stomach and duodenum,
one of the most prominent functions of TRPV1-expressing sensory nerves is the
maintenance of tissue integrity against noxious compounds, such as protons and activated
enzymes (Holzer, 2002). In airway hypersensitivity, capsaicin-responsive afferents are
either superficial fibers terminating in the mucosa or deep pulmonary fibers located in the
alveolar septa. Superficial fibers monitor the chemical environment of the airway mucosa
and their activation results in cough, increased mucosal secretion and bronchoconstriction
(Nagy et al., 2004). The TRPV1 channel plays an imperative role in the activation in
remote ischemic post-conditioning, as denervation of TRPV1 channel positive afferent
nerve fibers or blockade of the TRPV1 receptor was shown to significantly attenuate
remote ischemic post-conditioning-induced cardio-protective effects in rat hearts
(Randhawa and Jaggi, 2015). TRPV1 in perivascular plexi activated by low pH of the
ischemic heart muscle during insufficient coronary circulation (Franco-Cereceda et al.,
1993) contributes to the development of chest pain and reflectory sympathetic activation
(Zahner et al., 2003).

1.1.2 TRPV1 and pain

4

The nociceptive sensors in DRG neurons play a critical role in the transmission of pain;
therefore, the DRG has become an important target for pain treatment. The TRPV1
channel is one of the nociceptive receptors in DRG neurons. Studies with TRPV1deficient mice demonstrate that the TRPV1 channel is essential for the thermal
hyperalgesia induced by tissue injury and inflammation, supporting the hypothesis that
TRPV1 is a molecular integrator of painful stimuli (Caterina et al., 1997). Proteaseactivated receptor 2 (PAR2)-induced thermal hyperalgesia depends on sensitization of
TRPV1. In addition, PAR2 agonists and other inflammatory agents, including bradykinin,
adenosine triphosphate (ATP), prostaglandin E2 (PGE2) and nerve growth factor (NGF)
indirectly sensitize TRPV1, causing hyperalgesia. The mechanisms of this sensitization
include activation of PKC and PKA, which phosphorylate TRPV1 to modify channel
gating (Amadesi et al., 2006).

Capsaicin (the active ingredient of hot chili peppers and an agonist for the TRPV1
channel) and its vanilloid analogue, resiniferatoxin (RTX, from Euphorbia resinifera),
elicit burning pain by activating TRPV1 expressed on the sensory nerve endings (Szallasi
and Blumberg, 1999). TRPV1 antagonists alleviate pain behavior in rodent models of
inflammation (Honore et al., 2005). Interestingly, peripheral delivery of capsaicin causes
desensitization of sensory neurons (C fibers and Aδ fibers), thus alleviating pain as well
(Rains and Bryson, 1995). Early work by Bodnar et al demonstrated that
intracerebroventricular (ICV) capsaicin injection decreased the nociceptive threshold and
reduced morphine-induced analgesia (Bodnar et al., 1982; Bodnar et al., 1983). In
addition, the heat threshold of the tail, measured by an increasing-temperature water bath,
5

was significantly higher in TRPV1 knock out animals (Tekus et al., 2016). Modulation of
TRPV1 channels by dopamine in nociceptive neurons may represent a way for dopamine
to modulate incoming noxious stimuli (Chakraborty et al., 2016). One study showed that
diabetic thermal hyperalgesia was associated with a reduction in anti-nociceptive effects
of capsaicin (TRPV1 agonist) in the ventrolateral periaqueductal gray (VL-PAG) and
down-regulation of TRPV1 receptor expression in periaqueductal gray (PAG)
(Mohammadi-Farani et al., 2010). TRPV1 receptor stimulation by endocannabinoids or
by capsaicin in the PAG led to analgesia and this effect was associated with glutamate
increase and the activation of OFF cell population in the rostral ventromedial medulla
(Palazzo et al., 2008).

1.1.3 TRPV1 and inflammation

Experimentally, intradermal capsaicin injection induced neurogenic inflammation, and
was characterized by arteriolar vasodilation, plasma extravasation, and pain (hyperalgesia
and/or allodynia) (Jancso et al., 1967). The underlying mechanism is that capsaicin
sensitizes nociceptors by activating TRPV1 receptors distributed in small diameter
myelinated (Aδ) and unmyelinated (C) primary afferent nociceptive fibers, which leads to
the release of inflammatory peptides from these sensitized afferent terminals. In dorsal
root ganglia, more than 50% of neurons express TRPV1, and the majority of TRPV1
positive neurons respond to nerve growth factor (NGF) and release substance P (SP) and
CGRP producing neurogenic inflammation by interacting with endothelial cells, mast
cells, immune cells and arterioles. Bonnington et al reported that the early pathway in
6

TRPV1-mediated nociception activated by NGF involves phosphatidylinositol-3-kinase,
as well as PKC and CaMKII. Activation of this pathway results in inflammatory heat
hyperalgesia through TRPV1 sensitization (Bonnington and McNaughton, 2003). TRPV1
also plays a role in airway inflammation. Cough sensitivity to TRPV1 activators, such as
capsaicin or citric acid aerosol, was markedly elevated in patients with asthma or airway
inflammation (O'Connell et al., 1996). There was a significant correlation between the
cough sensitivity to capsaicin inhalation challenge and the density of TRPV1-expressing
nerves in the mucosa of patients with chronic cough (Groneberg et al., 2004). Some
studies have been done on TRPV1’s role in joint diseases. Increased expression of
TRPV1 on unmyelinated nerves was demonstrated during Complete Freund's Adjuvant
(CFA)-induced hind paw inflammation (Carlton and Coggeshall, 2001). Keeble
demonstrated the pathophysiological involvement of TRPV1 in a murine joint
inflammation model, acutely and chronically. The study examined the vascular and
hyperalgesic components of the joint inflammation in wild type mice and TRPV1
knockout mice after intra-articular injection of Complete Freund's Adjuvant (CFA), and
demonstrated that knee swelling and vascular hyper-permeability were significantly
higher in the CFA-treated joints of wild type mice than TRPV1 null mice, although
leukocyte accumulation and cytokine production were not affected (Keeble et al., 2005).
By limiting neuro-inflammatory processes, TRPV1 exerted a protective role that restricts
the initiation and progression of colon cancer (Vinuesa et al., 2012).

TRPV1 can be sensitized by many inflammatory mediators, indicating its important and
broad role in inflammation. Cumulative evidence demonstrated that nociceptor
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sensitization by inflammatory agents is primarily through potentiation of the TRPV1
channel activity. TRPV1 sensitization by pro-algesic agents occurs either through direct
activation of the channel or its potentiation. Direct activation of TRPV1 by arachidonic
acid metabolites including anandamide, N-arachidonoyl dopamine (NADA), Noleyldopamine and 12-hydroperoxyeicosatetraenoic acid has been reported. They act as
weak agonists, but potently increase TRPV1-mediated [Ca2+]i in both heterologous
expression systems and primary sensory neurons (Chu et al., 2003; Huang et al., 2002).
In addition, the acidosis that develops in inflamed tissues is also a direct activator of the
TRPV1 (Caterina and Julius, 2001). The potency and efficacy of each mediator is quite
low, but in inflammatory conditions several of these modulators are simultaneously
released and act synergistically.

1.1.4 TRPV1 and thermoregulation

Body temperature is regulated and maintained by several individual thermo-effectors
such as vasomotor tone in subcutaneous tissue. Non-shivering thermogenesis is
controlled by metabolic heat production in different tissues such as brown adipose tissue
and in the liver, controlled by adrenaline and thyroid hormones respectively. In contrast,
shivering thermogenesis is mediated by the skeletal muscle. Tonic TRPV1 activation
modulates vasomotor tone and thermogenesis. TRPV1 agonists cause hypothermia via
skin vasodilation and a reduction in metabolism. It was demonstrated that AMG0347 (a
selective TRPV1 antagonist) caused hyperthermia by vasoconstriction and an increase in
metabolism (Steiner et al., 2007). Accordingly, TRPV1 agonists cause hypothermia.
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Capsaicin caused hypothermia when administered by a variety of routes including oral,
intraperitoneal (i.p.) and intracerebral administration in a wide variety of animals such as
mice, rats, guinea pigs, dogs, goats and ground squirrels. Additionally, the ability of
capsaicin to cause hypothermia was not abolished or reversed in a hot environment (Hori,
1984), suggesting that ambient temperatures do not affect this response. Similar to
capsaicin, other agonists of TRPV1, such as RTX 4 and arvanil, also caused hypothermia
(Di Marzo et al., 2000). These data support the central role of TRPV1 in mammalian
thermoregulation.

There

are

cutaneous

thermo-sensors

and

visceral

thermo-sensors.

Visceral

thermoreceptors were considered to be within the walls of the rumen, intestine and
around the mesenteric vessels. Several recent reports provide evidence that TRPV1expressing capsaicin-sensitive visceral primary afferent neurons, their thoracic or
abdominal receptors and central terminals could serve as thermoreceptors within the
physiological range of thermoregulation (Szolcsanyi, 2015). Furthermore, the noxious
heat-sensitive groups of polymodal nociceptors are the major targets of capsaicin. After
treatment of rats with increasing doses of capsaicin within 2–4 days from 30–50 mg/kg
up to a total dose of 120–300 mg/kg, the animals became insensitive to capsaicin and
capsaicin did not induce hypothermia even after several months. Acute effects of
capsaicin are mediated by TRPV1 activation but long-term effects are due to sensory
desensitization of TRPV1-expressing neurons (Szikszay et al., 1982; Szolcsanyi, 2015).
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1.1.5 TRPV1 and vasculature

TRPV1 activation in blood vessels causes constriction effects (Kark et al., 2008). RT–
PCR showed the expression of TRPV1 mRNA in the brain, aorta, and primary cultured
VSMC from TRPV1 reporter mice (Cavanaugh et al., 2011). Expression of TRPV1 in
bladder was detected in arteriolar smooth muscle (ASM) in mice (Phan et al., 2016).
Expression of TRPV1 channels in aortic and skeletal muscle arteriolar myocytes have
been reported (Kark et al., 2008; Lizanecz et al., 2006). The expression of TRPV1 was
observed in human pulmonary artery smooth muscle cells (PASMCs) and is associated
with hypoxia-induced cell proliferation (Wang et al., 2008). TRPV1 activator capsaicin
increased hindlimb vascular resistance in vivo and caused substantial endotheliumindependent vasoconstriction of skeletal muscle arterioles in vitro. Vasoconstriction of
isolated canine mesenteric arteries following direct activation of TRPV1 channels has
also been reported (Porszasz et al., 2002). However, capsaicin evoked constrictions in
rats skeletal muscle arteries and carotid arteries, but had no effect on the femoral,
mesenteric arteries or the aorta (Toth et al., 2014). The study showed capsaicin-induced
vasodilation in the mesenteric arteries of normal rats (Zhang et al., 2015). Capsaicin
alone did not cause constriction in the conduit canine coronary artery, however, pretreatment with pro-inflammatory prostaglandin-thromboxane agonists may unmask
capsaicin's vasoconstrictive potential. Capsaicin first induced transient dilation that was
followed by sustained constriction in the conduit canine coronary artery (Hiett et al.,
2014). Increased cation permeability associated with TRPV1 channel activation results in
membrane depolarization and Ca2+ influx, which are the primary mechanisms by which
10

this channel causes vasoconstriction (Song et al., 2017). However, some evidence suggest
TRPV1 may be involved in store operated Ca2+ entry (SOCE) through functioning as
Ca2+ release channels in the sarcoplasmic reticulum (SR) in the RBL-2H3-M1 cells
(Turner et al., 2003). Calcium imaging of isolated arterioles from the ear showed that
genetically marked SMCs respond to capsaicin application, leading to arteriole
constriction. More recent work has revealed the presence of TRPV1 channels in murine
arteriolar myocytes located in thermoregulatory tissues and has demonstrated a role for
these channels as mediators of myocyte Ca2+ entry and constriction in intact auricular
arterioles (Cavanaugh et al., 2011).

Besides constriction, TRPV1 activation also causes dilation, which was found to be
related to the perivascular sensory neuronal terminals, which release neurotransmitters
(CGRP) upon stimulation and mediate vasodilation (Zygmunt et al., 1999). Capsaicin
elicited concentration-dependent vasodilation of both rat aorta and porcine coronary
arteries (Hopps et al., 2012). TRPV1 activation has been recently reported to decrease
phosphorylation of endothelial NO synthase (eNOS) at threonine 497 (Thr497) in
cultured bovine aortic endothelial cells, leading to increased NO production and
vasodilation (Ching et al., 2013). Capsaicin also abolished the concentration-dependent
constriction of porcine coronary arteries induced by the L-type calcium activator, Bay-K
8644. These data suggested that capsaicin causes vascular dilation through the inhibition
of L-type Ca²⁺ channels (Hopps et al., 2012).
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TRPV1 mRNA distribution in dorsal root ganglia, spinal cord and arteries in a study
(Toth et al., 2014) is summarized in Fig.1. TRPV1 distribution in tissues and detection
methods are summarized in Table.1.

Figure 1. TRPV1 mRNA in peripheral tissues of the rat.
TRPV1 expression was examined with qPCR in
peripheral tissues of the rat (Toth et al., 2014).
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Table.1. TRPV1 distribution in various tissues and the identification methods

TRPV1 containing tissues
Human dorsal root ganglia
Human kidney, pancreas, stomach, small
intestine, lung

Human skin and mouse ear
Rat dorsal root ganglia
Rat cerebral cortex, striatum,
hippocampus, central amygdala,
cerebellum, locus, cerulean, cochlear
nuclei, spinal nucleus of the trigeminal
nerve, inferior olive and spinal cord
Rat kidney, pancreas, placenta and
urinary bladder
Rat astrocytes
Rat renal artery
Mouse esphagus
Mouse asymmetric synapses in mouse
dentate molecular layer
Mouse trigeminal ganglion dura afferents
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Methods
Immunostain (Anand et al., 2006)
RT-PCR, Radioimmunoassay,
immunohistochemistry (Sharrad et al.,
2015; Wick et al., 2006; Zhao et al.,
2016; Zhu et al., 2005)
Immunohistochemistry, histology
(Denda et al., 2001)
Electrophysiology (McDonald et al.,
2008)
RT-PCR (Cavanaugh et al., 2011;
Huang et al., 2014; Liapi and Wood,
2005; Toth et al., 2005)

RT-PCR, isolated perfused rat
kidney, electrophysiology (Li and
Wang, 2008; Zhu et al., 2011)
Immunohistochemistry (Sharrad et
al., 2015)
RT-PCR (Ueda et al., 2008)
Immunohistochemistry (Matsumoto et
al., 2014a)
Immunolocalization (Puente et al.,
2015)
Immunohistochemistry (Huang et al.,
2012)

1.2 Serotonin

1.2.1 General overview of serotonin

Serotonin, also known as 5-hydroxytryptamine (5-HT), was initially isolated from
bovine serum as a substance with vasoconstriction effects (Cavanaugh et al., 2011).
Serotonin is synthesized from dietary L-tryptophan via an intermediate compound, 5hydroxytryptophan (5-HTP) by the enzyme tryptophan hydroxylase (TPH). At least 15
distinct 5-HT receptor subtypes have been found, which are grouped into 7 families with
distinct downstream signaling pathways (Kroeze et al., 2002). More than 90 % of 5-HT
found in the body is synthesized and stored in enterochromaffin cells in the gut. In the
gastrointestinal (GI) tract, 5-HT acts as a critical signaling molecule participating in
intestinal secretion, sensation, and peristalsis. These effects predominantly signal through
5-HT (3) and 5-HT (4) receptors (Gershon, 1999). Enteric neuronal 5-HT has a vital role
in the growth and maintenance of intestinal mucosa and 5-HT promotes development of
enteric neurons and proliferation of central nervous system neuronal precursors, and
induces adult stem cells to undergo neurogenesis (Gross et al., 2012). Platelets actively
take up 5-HT as platelets pass through the GI tract and provide a circulating reservoir
(Bertrand and Bertrand, 2010). In healthy human subjects, the mean level of 5-HT is
approximately 1 nM in plasma, 1µM in serum, and 400 µM in platelets (Flachaire et al.,
1990). When platelets bind to a clot, they release serotonin, which serves as a
vasoconstrictor and helps to regulate hemostasis and blood clotting. 5-HT is also a
monoamine neurotransmitter. A small proportion of 5-HT is enclosed within synaptic
14

vesicles of central serotonergic neurons as a neurotransmitter, which, after releasing, will
display its major physiological function in nerve terminals (Gamoh et al., 2013). 5-HT is
found extensively in neurons in the central and peripheral nervous systems and following
release, its actions are terminated by re-uptake and/or metabolism by monoamine oxidase
(MAO). Serotonin in the central nervous system (CNS) has long been associated with
pain processing and modulation (Eide and Hole, 1993). 5-HT from the rostral
ventromedial medulla (RVM) is an important contributor to pain facilitation during the
development of persistent pain (Wei et al., 2010). Besides modulation in pain, 5-HT is
participating in many kinds of ischemia. During myocardial ischemia-reperfusion,
serotonin accumulates in the myocardial interstitium and plays an important role in the
progression of myocardial cell injury (Naumenko et al., 2014).

1.2.2 Serotonin receptors

5-HT functions via 15 classes of receptors that are present (and differentially distributed)
in the cardiovascular system, peripheral nervous and central nervous systems (CNS),
including the frontal cortex, hippocampus, amygdala, striatum, hypothalamus and dorsal
horn. All (intronless) 5-HT1 receptors negatively couple to adenylyl cyclase (AC) via Gi/o,
whereas 5-HT4, 5-HT6 and 5-HT7 receptors stimulate AC through Gs. 5-HT2 triplets (A,
B and C) share recruitment of phospholipase C (PLC) via Gq/11 as their modes of
signaling (Nakajima et al., 2009). Previous reports have indicated that 5-HT1-5 receptors
are involved in the modulation of nociception in the spinal cord (Jeong et al., 2004). 5HT receptor types on C-fibers, including 5-HT2A, 5-HT2B, 5-HT2C, 5-HT3, 5-HT4, 5-HT6
15

and 5-HT7 receptors, have been reported to mediate 5-HT-induced pro-nociceptive
effects at the periphery nervous system (Godinez-Chaparro et al., 2011; Sasaki et al.,
2006; Sommer, 2004). Besides central nervous system and peripheral nervous system, the
expression of mRNA of 5-HT1, 5-HT2 and 5-HT7 receptors has been reported in vascular
smooth muscle cells (VSMCs) (Machida et al., 2013). 5-HT2A and 5-HT1 receptor
subtypes are almost exclusively responsible for vasoconstriction (Yildiz et al., 1998).
Specifically, activation of 5-HT1B receptors produces vasoconstriction of large arteries
and veins, whereas 5-HT2B activation induces vasodilation of the microcirculation
(Arreola-Ramirez et al., 2015).

1.2.3 Role of serotonin in the gut

Serotonin receptors are widely expressed within the GI tract, and five of the seven
known families, 5-HT1, 5-HT2, 5-HT3, 5-HT4, and 5-HT7 receptors, are expressed in the
gut and can affect gut functions (Hoyer et al., 2002). Three subtypes of 5-HT receptor (5HT1p, 5-HT3, and 5-HT1A) have been found on enteric neurons. 5-HT1P receptors and
perhaps 5-HT3 receptors in neurons are involved in initiating the peristaltic reflex and
regulating gastric emptying (Gershon et al., 1990). Antagonists of 5-HT3 and/or 5-HT4
receptors slowed intestinal motility and a study demonstrated that corticotropin-releasing
hormone-induced defecation was blocked by the peripheral action of the 5-HT3 receptor
antagonist, ramosetron (Miyata et al., 1998). 5-HT3 receptor antagonists and 5-HT4
receptor agonists have been used to treat functional disorders such as diarrhea and
constipation (Camilleri, 2009). Other functions of 5-HT involving intrinsic reflexes
16

include stimulation of propulsive and segmentation motility patterns, epithelial secretion
and vasodilation. A unique feature of the gut is the ability of intrinsic reflex circuitry to
locally regulate blood vessel diameter that is achieved by mucosal stimulation. The
intrinsic reflex circuitry was blocked by inhibition of 5-HT3 and 5-HT4 receptors (Vanner
and Macnaughton, 2004). 5-HT3-mediated synaptic responses participate in descending
pathways in the myenteric plexus. However, functional studies examining the polarity of
intestinal reflexes demonstrated that ascending but not descending reflexes were inhibited
by 5-HT3 receptor antagonists (Yuan et al., 1994). Mechanical stimulation of the mucosal
surface leads to 5-HT release, which activates neural mediated Cl- and bicarbonate
secretion. Infusion of hyperosmotic solutions or carbohydrate breakdown products into
the lumen of the duodenum evokes release of 5-HT from EC cells and 5-HT acts on 5HT3 receptors to stimulate vagal afferent neurons (Li, 2007). Serotonin released from EC
cells is an important activator of the reflex-mediated secretion like neurotransmitters such
as acetylcholine and vasoactive intestinal peptide (VIP) (Kim et al., 2001). Within the gut,
5-HT also exerts actions such as promoting inflammation and serves as a trophic factor to
promote the development and maintenance of neurons and interstitial cells of Cajal
(Furness and Costa, 1982; Galligan et al., 2000).

1.2.4 Role of serotonin in central nervous system (CNS)

5-HT receptor family including different subtypes is involved in the functional
pathways in the brain and their balance in activity helps to maintain the mental stability.
In the CNS, serotonergic cell bodies are clustered in the midbrain and brainstem raphe
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nuclei from which they project locally, as well as to spinal cord and many forebrain
targets (Moore et al., 1978). The contributions of 5-HT include modulation of a broad
range of targets, most notably, hypothalamic, limbic and cortical circuits linked to the
control of mood and mood disorders. Dysregulation of 5-HT signaling has been
implicated in multiple neurobehavioral disorders, including anxiety, depression,
obsessive-compulsive disorder (OCD) and addiction (Moore et al., 1978). 5-HT3 receptor
is ubiquitously expressed in the central nervous system. Sites of expression include
several brain stem nuclei and higher cortical areas such as the amygdala, hippocampus,
and cortex. On the subcellular level, both presynaptic and postsynaptic 5-HT3 receptors
can be found. Presynaptic 5-HT3 receptors are involved in mediating or modulating
neurotransmitter release (Chameau and van Hooft, 2006). Serotonin transporter (SERT)
is antagonized by the 5-HT selective reuptake inhibitors (SSRI) that are used as
antidepressant medications that continue to represent the most common pharmacological
treatment for affective disorders (Blakely et al., 1998).

1.2.5 Role of serotonin in pain sensation and inflammation

Most studies of 5-HT have been focused on two central levels of pain control: the
dorsal horn of the spinal cord and the midbrain, which are anatomically and functionally
interconnected by a spino-bulbo-spinal loop (the brain's feedback to the spinal cord)
(Saade and Jabbur, 2008). Systemic (subcutaneous or intravenous) injections of 5-HT
trigger excitation and sensitization of primary nociceptive afferent fibers (Aδ and C fibers)
as well as nociceptive neurons originated in dorsal root ganglia, thereby contributing to
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peripheral sensitization and hyperalgesia (Sommer, 2004). Relevant studies in various
animal models showed that most if not all 5-HT receptor types, namely 5-HT1A, 5-HT1B,
5-HT1D, 5-HT1F, 5-HT2A, 5-HT2B, 5-HT2C, 5-HT3, 5-HT4, 5-HT5, 5-HT6 and 5-HT7, are
involved in modulatory mechanisms of nociception (Kayser et al., 2011). Indeed, spinal
5-HT, released from the serotonergic projections in response to formalin injection,
activates pre- or post-synaptic 5-HT (4/6/7) receptors at the dorsal root ganglion/spinal
cord, promoting the development and maintenance of secondary allodynia and
hyperalgesia (Godinez-Chaparro et al., 2012).

5-HT, a potent immune modulator, plays a role in inflammation pain sensation. 5-HT is
released from platelets and mast cells during inflammation or injury (Dray, 1995).
Enterochromaffin cells (EC) isolated from patient’s mucosa with the inflammatory
disease such as Crohn’s disease have a greater production of 5-HT (mediated in part by
Toll-like receptor 4). Patients with another inflammatory disease ulcerative colitis have
reduced expression of serotonin transporter (SERT), and it is also observed in another
form of intestinal inflammation, diverticulitis (Coates et al., 2004; Costedio et al., 2008;
Kidd et al., 2009). Rheumatoid arthritis (RA) is a systemic inflammatory disorder that
principally attacks synovial joints, characterized by cartilage erosion and ankylosis, and
is associated with increased levels of circulating 5-HT (Voog et al., 2004). In
inflammation-induced pain, both peripheral 5-HT2A receptors and 5-HT2C receptors are
involved. Local application of a selective 5-HT2A/2C receptor antagonist may be effective
to treat pain provoked by 5-HT release, which commonly occurs with inflammation
(Nakajima et al., 2009) .
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1.2.6 Role of serotonin in the cardiovascular system

Serotonin induces a wide spectrum of effects in the cardiovascular system, mediated
through a variety of receptor subtypes. 5-HT is taken up by serotonin transporter (SERT)
in platelets, as platelets do not synthesize 5-HT. The function of 5-HT in the blood is to
promote platelet aggregation and blood clotting (Mauler et al., 2016). Although platelets
contain 5-HT, they also possess 5-HT2A receptors which, when activated, promote further
platelet activation and aggregation (Watts, 2005). Thus 5-HT2A receptor antagonists such
as ketanserin and sarpogrelate have been proved effective as anti-platelet/anti-thrombotic
agents. Interestingly, reports have described platelets in hypertensive subjects as being
hyper-aggregatable or more fragile. Aspirin (a platelet aggregation inhibitor inhibiting 5HT release from platelets) attenuates pulmonary arterial hypertension in rats by reducing
the plasma 5-HT level (Shen et al., 2011). In several models of chronic hypertension,
there are a specific increase in the responsiveness of the blood vessel wall to the
vasoconstrictor property of 5-HT and a delayed desensitization to the monoamine. The
ability of hypertensive animals to clear 5-HT from the blood is reduced, and the platelets
of hypertensive patients take up less 5-HT than those of normotensive humans; their
activation to release 5-HT is accelerated (Vanhoutte, 1983). After 5-HT is released from
platelets, vasoconstrictive effect of 5-HT is mediated by 5-HT1B and 5-HT2A receptors
located on the membrane of smooth muscle cells, except in the intracranial arteries whose
constriction are only mediated by 5-HT1B receptors (Gamoh et al., 2013). Constriction of
mice pulmonary arteries by 5-HT was attenuated by applying GR-127935 (a 5-HT1B/1D
receptor inhibitor) (Liu and Folz, 2004). 5-HT1D-like receptor mediates constriction in the
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canine coronary artery (Cushing et al., 1994). 5-HT-induced canine internal carotid
arteries and rat middle cerebral arteries constriction is predominantly mediated by 5HT1B/1D and 5-HT2A receptors (Centurion et al., 2001; Kovacs et al., 2012). 5-HT2A
receptors mediate the serotonin-induced constriction in the rabbit aorta (Clancy and
Maayani, 1985), dog femoral arteries (Apperley et al., 1980), and many other arteries
from several species (Martin, 1994). Receptor-coupled stimulation of artery constriction
involves elevating smooth muscle intracellular Ca2+ levels and also sensitizing the
myofilaments to the [Ca2+]i increase (MacDonald et al., 2000).

There are limited studies about 5-HT effect on carotid artery tone and the facial artery is
an important extracranial artery from the external carotid artery territory that is involved
in the head hemodynamic. Thus, studying the 5-HT’s constriction role in the facial artery
improves our understanding of the head blood flow regulation under common
endogenous substances such as 5-HT, which may provide a potential drug target for head
blood dysregulation diseases such as stroke and migraine headache. Common carotid
artery vasoconstriction response to 5-HT in vagosympathectomized dogs is mainly
mediated by activation of sumatriptan-sensitive 5-HT1-like receptors (Villalon et al.,
1995). 5-HT can produce vasodilatation or vasoconstriction of the canine external carotid
bed depending upon the degree of carotid sympathetic tone. 5-HT1B receptors and alpha
2A/2C-adrenoceptors

mediate

external

carotid

artery

vasoconstriction

to

dihydroergotamine (a 5-HT1D receptor agonist used to treat migraine) (Villalon et al.,
2004). Serotonin elicited a biphasic concentration response curve (CRC) in the rat
femoral artery, the first phase of the serotonin CRC in rabbit femoral artery is mediated
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predominantly by 5-HT2 receptors and that the second phase is mediated by alpha 1adrenoceptors (Grandaw and Purdy, 1996). 5-HT-mediated pulmonary arterial
vasoconstriction occurs largely due to the activation of 5-HT2 receptors, which then
activates Gq-coupled pathways and increases cytosolic calcium leading to arterial
constriction. 5-HT also acts as a vasodilator because it releases nitric oxide from
endothelial cells. This response is mediated by 5-HT1B receptors but not by 5-HT2A
receptors (Gamoh et al., 2013). Our study mainly focuses on 5-HT constriction
mechanism by studying serotonin receptor subtypes and downstream signaling pathways
in the facial artery constriction. 5-HT receptors distribution within the vasculature is
listed in Table.2.
Table.2 5-HT receptors distribution in the vasculature
Receptor
subtype
5-HT (1A)
5-HT (1B)

5-HT (1D)

Distribution and effect
Rat renal artery relaxation (Nakajima et al., 2009)
Human coronary artery constriction (Bopp et al., 2016)
Human pulmonary artery constriction (Bopp et al., 2016)
Human cerebral artery constriction (Comer, 2002)
Human mesenteric artery constriction (Gul et al., 2003)
Human temporal artery constriction (van den Broek et al., 2002a)
Human middle meningeal artery constriction (van den Broek et al.,
2002a)
Human coronary artery dilation via endothelium cells (Ishida et al.,
1998)
Rat pulmonary artery constriction (Wang et al., 2001)
Rat middle cerebral artery constriction (Kovacs et al., 2012)
Human coronary artery and middle meningeal artery constriction (van
den Broek et al., 2002b)
Human temporal artery constriction (Verheggen et al., 1996)
Human pulmonary artery constriction (MacLean et al., 1996)
Human internal thoracic artery constriction (Chester et al., 2000)
Endothelium cells of human coronary artery causing dilation (Ullmer et
al., 1995)
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5-HT (1F)
5-HT (2A)

5-HT (2B)

5-HT (4)
5-HT (7)

Relaxation through endothelium cells of pig coronary artery (Chan et
al., 2013)
Canine denuded coronary artery constriction (Egashira et al., 1992)
Human middle meningeal artery constriction (Razzaque et al., 1999)
Human coronary arteries (Nilsson et al., 1999)
Human temporal artery constriction (Verheggen et al., 1996)
Human pulmonary artery constriction (Cogolludo et al., 2006)
Human internal thoracic artery constriction (Tanaka et al., 2008)
Pig coronary artery constriction (Miyata et al., 2000)
Rats mesenteric arteries constriction (Sung et al., 2013)
Rats middle cerebral artery (Back et al., 1998)
Rats common carotid artery constriction (Radenkovic et al., 2010)
Aorta of larval (Majeed et al., 2014)
Endothelium cells of pig meningeal artery causing dilation (Schmuck et
al., 1996)
Pulmonary artery in weaned pigs dilation (Jahnichen et al., 2005)
Endothelium cells of human coronary artery causing dilation (Ishida et
al., 1998)
Human pulmonary endothelium cells (Ullmer et al., 1996)
Endothelium cells of human coronary artery (Ullmer et al., 1995)
Human coronary artery (Nilsson et al., 1999)
Human pulmonary artery (Ullmer et al., 1995)
Middle meningeal artery of rats dilation (Terron and Martinez-Garcia,
2007)

1.3. Relationship between 5-HT receptors and TRPV1

5-HT receptors can regulate TRPV1 function in various tissues that are associated with
many physiological processes. Sumatriptan (10 µM), a selective antimigraine drug (5HT1 receptor agonist), inhibited TRPV1-mediated inward currents in trigeminal ganglia
(TG) and capsaicin-elicited spontaneous excitatory postsynaptic currents in trigeminal
nucleus caudalis (TNC) slices (Evans et al., 2012). 5-HT2B receptor mediates 5-HTinduced mechanical hyperalgesia by upregulating TRPV1 function (Su et al., 2016).
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Studies demonstrate that 5-HT2 and 5-HT7 receptors in nervous system are modulating
TRPV1 channel. Stimulation of spinal 5-HT (2A/2C) receptors potentiates the capsaicininduced release of substance P-like immunoreactivity in the rat dorsal horn (Kjorsvik
Bertelsen et al., 2003). PKC and PKA-mediated signaling pathways are involved in the
potentiating effect of 5-HT on TRPV1 functions through the activation of 5-HT2A and 5HT7 receptors respectively in cultured dorsal root ganglion (DRG) neurons isolated from
neonatal rats (Ohta et al., 2006). 5-HT-induced facilitation of TRPV1 function was
significantly reversed by SB204070 (a selective 5-HT4 receptor antagonist) and this
facilitation is probably due to activation of 5-HT4 receptors. Activation of both 5-HT2 and
5-HT4 receptors similarly enhanced TRPV1 function in colon sensory neurons. 5-HT2
receptor agonists mimicked the facilitating action of 5-HT on TRPV1 function in
response to acid (Sugiuar et al., 2004).

Protein kinase C (PKC) can be regarded as a molecule that links 5-HT receptors
(specifically 5-HT2 receptor) and TRPV1 channels. TRPV1 was sensitized at the knee
joint and at DRG neurons of mono-iodoacetate-induced joint pain in rats through PKC
activation (Koda et al., 2016). PKC activation has also been shown to increase TRPV1
activity by inflammatory mediators such as bradykinin (Wang et al., 2015). 5-HT2
receptor activation leads to activation of Gq/11, resulting in activation of phospholipase C
(PLC) and PKC (Conn and Sanders-Bush, 1984; Roth et al., 1986). 5-HT-induced
mechanical hyperalgesia may be mainly mediated by 5-HT2B-Gq-PLCβ-PKCε signaling
by regulating TRPV1 function (Su et al., 2016). Besides PKC and TRPV1, 5-HT-induced
contraction (also 5-HT2A-mediated contraction) is coupled with various kinase pathways
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including mitogen-activated protein kinase (MAPK), Phosphatidylinositol-4, 5bisphosphate 3-kinase (PI3K), and Rho kinase in smooth muscle cells (SMCs)
(Matsumoto et al., 2014b). Caldesmon is a physiological substrate of p44/42 MAPKs and
inhibits the ATPase activity of actin-myosin complex in smooth muscles. Phosphorylated
caldesmon positively regulates smooth muscle contraction by relieving the inhibition of
actin-myosin ATPase activity and, consequently, promoting smooth muscle contraction
(Gerthoffer et al., 1996; Matsumura and Yamashiro, 1993). PI3Kγ isoform generates PIP3,
which eventually stimulates L-type calcium channels in vascular myocytes (Le Blanc et
al., 2004). RhoA/Rho kinase-mediated Ca2+ sensitization is generally attributed to the
inhibition of myosin light chain phosphatase, increased myosin light chain
phosphorylation and increased vascular tone (Broughton et al., 2008).

Preliminary studies in our laboratory indicated that PKC is involved in capsaicininduced mouse middle meningeal artery constriction and is a necessary component in
sustained constriction (unpublished observations by Hughes, Wellman et al.). In the
present study, serotonin induced facial artery constriction. PKC, a downstream molecule
for 5-HT2 receptors activation (Zhang et al., 2003), clues to a possible link between the
TRPV1 channel and 5-HT receptors in arteries. Therefore, we hypothesized that TRPV1
is involved in 5-HT-induced facial artery constriction. We further propose the
constriction effect of serotonin on the facial artery via opening of TRPV1 channels is
mediated by 5-HT2 but not 5-HT1 receptors due to PKC’s potential role in modulating
both TRPV1 and 5-HT2 receptors. In the present study, we found that TRPV1 inhibition
cannot suppress sumatriptan (5-HT1 receptor agonist) constriction, suggesting that 5-HT25

induced facial artery constriction via opening of TRPV1 may signal through 5-HT2
receptors, not 5-HT1 receptors.
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CHAPTER 2: RESEARCH STUDY

2.1. Introduction

TRPV1, a member of the TRP family of ion channels, is a non-selective cation channel
(high calcium permeability), which is activated or modulated by diverse exogenous
noxious stimulus such as high temperatures, irritant and pungent compounds, and by
selected molecules released during tissue damage and inflammatory processes.
Endogenous regulators of TRPV1's activity include acidic pH and anandamide which
activate TRPV1, lipids and lipids metabolites that negatively regulate TRPV1, for
example cholesterol and phosphatidylinositol 4, 5-biphosphate (PIP2) (Bevan et al., 2014).
TRPV1 was found in the central nervous system (Toth et al., 2005) and peripheral blood
vessels (Lizanecz et al., 2006). Later research on the effects of TRPV1 stimulation in
blood vessels suggested both dilation and constriction (Kark et al., 2008). TRPV1mediated dilation was found to be related to the perivascular sensory neuronal terminals,
which released neurotransmitters (calcitonin gene-related peptide CGRP, substance P)
upon stimulation and mediated vasodilation (Rosenbaum and Simon, 2007). The
vasoconstrictive properties of TRPV1, however, were much less well characterized.
TRPV1 is expressed in a subset of arteriolar smooth muscle cells within thermoregulatory
tissues and capsaicin (a TRPV1 agonist) increases calcium influx and induces
vasoconstriction (Cavanaugh et al., 2011). Capsaicin evoked constrictions in skeletal
muscle arteries, carotid arteries and femoral arteries, but had no effect on mesenteric
arteries or the aorta (Toth et al., 2014). However, constriction of isolated canine
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mesenteric arteries following direct activation of TRPV1 channels has been demonstrated
(Porszasz et al., 2002). Expression of TRPV1 channels in aortic and skeletal muscle
arteriolar myocytes from rats has been reported (Lizanecz et al., 2006; Toth et al., 2014).
We previously found functional expression of TRPV1 channels in ASM of arteries and
arterioles of the cephalic, cutaneous and skeletal muscle circulations (unpublished
observations by Koide, Wellman et al.). Using our TRPV1-td Tomato reporter mice
(using the Cre/loxP system to express the red fluorescent protein, tdTomato, under the
control of the entire TRPV1 gene promoter region, yielding a staining pattern that
recapitulates endogenous TRPV1 expression), we have established the presence of
TRPV1 throughout the external carotid artery (ECA) territory and demonstrated its
complete absence in the cerebral vasculature. Capsaicin constricted facial arteries (FA)
and middle meningeal arteries (MMA) that are from the external carotid artery. In
significant contrast, capsaicin did not constrict cerebral arteries from wild type mice or
MMA)/FA from TRPV1-knock out mice (unpublished observations by Koide, Wellman
and Brayden et al.). PKC is involved in endothelin-1 potentiating effect on TRPV1 and
this plays a major role in hyperalgesic effects of endothelin-1 in sensory neurons (Plant et
al., 2007). PKCε phosphorylates TRPV1 at Ser800 and sensitizes nociceptors (Aley et al.,
2000). PKC is the downstream molecule for Gq\11-protein-coupled receptors (Mironneau
and Macrez-Lepretre, 1995). The present study showed 5-HT caused facial artery
constriction, which is probably through binding with 5-HT receptors. Specifically, 5-HT2
receptor is Gq\11-protein-coupled receptor that can activate PKC through generating
diacylglycerol (DAG). Thus we speculated TRPV1 is involved in 5-HT-induced facial
artery constriction.
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Serotonin (5-HT) is a bioamine derived from the amino acid tryptophan. Seven classes
of serotonin receptors have been identified (5-HTR1 to 5-HTR7). Among them, 5-HT3
receptor is the only ligand-gated ion channel receptor. All other serotonin receptors
belong to the G-protein-coupled receptor superfamily. The 5-HT1A, 5-HT1B/1D, 5-HT2
receptor family (5-HT2A and 5-HT2B), 5-HT3, 5-HT4 and 5-HT7 receptors are found in
cardiovascular tissues (Cote et al., 2004; Doggrell, 2003; Marwood and Stokes, 1984;
Ramage and Villalon, 2008). 5-HT2A and 5-HT1 receptor subtypes are almost exclusively
responsible for vasoconstriction (Yildiz et al., 1998). Vasoconstriction of the external
carotid artery induced by 5-HT in vagosympathectomized dogs is mainly mediated by
activation of sumatriptan-sensitive 5-HT1 receptors (Villalon et al., 1995). 5-HT caused a
constriction response both in the external and internal carotid vascular beds, ketanserine
(10 nM) (5-HT2 receptor antagonist) antagonized both responses, indicating the
involvement of 5-HT2 receptors (Vasquez and Pinardi, 1992). The mesenteric artery
constriction to 5-HT (seconds-minutes) from normotensive rats is mediated primarily by
5-HT2A receptors (Watts et al., 1996). 5-HT1 receptor family is mostly linked to Gi/o
protein, which inhibits cAMP formation, whereas 5-HT2 receptor is coupled to Gq/11
protein leading to the activation of IP3/PKC/cytosolic [Ca2+] signaling pathway (Martin et
al., 1998).

Tight regulation of cephalic blood circulation is critical under normal physiological
conditions, and dysregulation of blood flow to the head occurs in pathophysiological
situations such as stroke and migraine headache. The facial artery is an extracranial artery,
which is a branch from the external carotid artery territory and its position indicates its
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importance in regulating hemodynamics in the head. In the systemic circulation,
serotonin activates a variety of direct and reflex responses including vasospasm. TRPV1
is found to have vasoconstrictive effect in many vascular beds. In the present study, we
studied the endogenous substance serotonin (5-HT) constriction in the facial artery from
the external carotid artery territory and its relation with TRPV1 channels. In terms of 5HT-induced constriction, 30 nM 5-HT induced mouse facial artery constriction and this
constriction was not desensitized (data not shown). We studied TRPV1 channel
involvement in 5-HT-induced facial artery constriction by examining blocking of TRPV1
channel on 5-HT constriction, and 5-HT receptor subtypes in mediating 5-HT-induced
constriction via opening of TRPV1 channels. Using pressurized arteriography
measurements, our ex vivo data firstly showed that 5-HT-induced constriction of the
facial artery can be partly inhibited by applying the TRPV1 antagonist capsazepine or Ltype-voltage–dependent Ca2+ channels (L-VDCC) inhibitor nifedipine. We found that
protein kinase C (PKC) may involve in capsaicin-induced constriction in the facial artery,
which suggests that 5-HT receptor subtype 2 is probably involved in serotonin-induced
facial artery constriction via opening of TRPV1 channels. We found 5-HT1 and 5-HT2
receptors are the main 5-HT receptor subtypes that mediate 5-HT-induced facial artery
constriction. We used 5-HT + GR55562 (5-HT1 receptor antagonist) to activate 5-HT2
receptor in the facial artery and found that capsazepine significantly blunted this
constriction. Furthermore, we demonstrated that 10 µM sumatriptan (5-HT1 receptor
agonist) caused facial artery constriction, that was unaffected by capsazepine. This
indicated that 5-HT1 receptor is not involved in serotonin-induced facial artery

30

constriction via opening of TRPV1 channels. Thus, activation of TRPV1 channels is
involved in 5-HT-induced 5-HT2 receptor-mediated mouse facial artery constriction.
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2.2. Methods and Material

Dissection of the facial artery and the arteriography diameter measurement

All experiments and protocols were performed in accordance with the Guide for the
Care and Use of Laboratory Animals (eighth edition, 2011) and were approved by the
Institutional Animal Care Committee of the University of Vermont. Male C57BL/6J mice
(20 to 23 g body weight) and TRPV1-knock out (KO) mice were used in this study (from
Jackson Labs). Specifically, TRPV1 knock out (KO) mice were generated by targeted
deletion of exons encoding the fifth and sixth transmembrane domains of the channel,
including the pore-loop domain (Caterina et al., 2000). Mice were anesthetized using
pentobarbital salt solution (0.02 ml per mouse, pentobarbital sodium 390 mg/ml) and
sacrificed by decapitation. The head was preserved in 4°C physiological salt solution
(PSS; NaCl 119 mM, KCl 4.69 mM, KH2PO4 1.69 mM, MgSO4 1.18 mM, EDTA 0.033
mM, NaHCO3 23.81 mM, Glucose 10.55 mM, CaCl2 1.6 mM). Facial arteries from
C57BL/6J mice were dissected using a light microscope (Fiber-Lite, Dolan-Jenner
Industries) in cold physiological salt solution (PSS). Then the artery was pinned down in
a dissection dish with PSS and cleaned to remove all connective tissues. For endothelial
cell removal, arteries were cannulated on a system in which the proximal cannula and
perfusion tubing were pre-filled with 1–2 ml of air using a syringe attached to the LuerLok inflow port. Air bubbles were run slowly through the lumen to remove the
endothelial cells. A 3-4 mm piece of artery was cannulated in a chamber filled with PSS
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and intravascular pressure was adjusted to 20 mmHg using a pressure servo-controller
and a peristaltic pump (Living Systems Instruments, St. Albans, VT) as previously
described (Ishiguro et al., 2002). PSS was bubbled with mixed gas (20% O2 / 5% CO2 / 75%
N2) to maintain physiological pH (7.35-7.4). Arteries were continuously superfused with
warmed PSS (37°C). Vessel diameters were measured by video edge detection (Living
Systems Instrumentation, St Albans, VT) and WinDaq data acquisition software (Dataq
Instruments, Akron, OH). Following equilibration for 30 minutes, arterial viability was
evaluated by brief exposure to 60 mM KCl (< 2 min; isosmotic replacement of NaCl with
KCl in PSS). Only arteries that demonstrated a constriction represented by decrease in
diameter of 50% or greater were used in subsequent studies. Perfused drugs for all
subsequent studies were dissolved in PSS.

Calculation of artery constriction

Baseline was defined as the pressurized arterial diameter at 80 mmHg with or without
addition of antagonists. Arterial constriction induced by agonists was calculated as a
percentage of decrease in diameter from the baseline {percent of constriction =
[(diameter before adding the drug – average diameter after adding the drug) / diameter
before adding the drug] × 100%}. The fully dilated (passive) arterial diameter was
determined at the end of each experiment by exposing arteries to Ca2+-free PSS
containing nondihydropyridines (non-DHP) calcium channel blocker, diltiazem (100
µmol/L) and the adenylyl cyclase activator, forskolin (1 µmol/L).
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Statistical analysis

The data are presented as mean ± S.E.M of at least three independent experiments. Oneway analysis of variance followed by Tukey multiple comparison test was used to
compare groups. P values less than 0.05 were considered statistically significant (*P ˂
0.05). Power calculations indicated the power possibility (%) to get statistical
significance (*P < 0.05) under certain repetitive experiments times (N).

Reagents

5-HT and nifedipine were purchased from Sigma. Capsaicin, capsazepine, GR55562
dihydrochloride and ritanserin were purchased from Tocris. Sumatriptan, 2, 5-dimethoxy4-Iodoamphetamine (DOI hydrochloride), forskolin, chelerythrine and phorbol 12myristate 13-acetate (PMA) were purchased from Cayman.
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2.3. Results

Inhibition of TRPV1 channel blunted serotonin-induced facial artery constriction.

Using TRPV1–tdTomato–reporter mouse, our lab found there is TRPV1 in smooth
muscle cells but no TRPV1 in endothelial cells or perivascular nerves in the facial artery
bed (unpublished observations by Wellman, Brayden and Koide et al.). We found that 5HT (30 nM) evoked facial artery constriction by the arteriography diameter measurement
(Fig. 2A). TRPV1 is a cation channel that has high permeability for Ca2+ and increase of
intracellular Ca2+ causes smooth muscle cell contraction. Thus we speculated 5-HTinduced facial artery constriction is via opening of TRPV1 channels. 5-HT (30 nM)
constricted facial arteries to 40.98 ± 3.02% (Fig. 2B). Percent of constriction of the facial
artery with 30 nM 5-HT was reduced to 24.94 ± 5.71% in the presence of TRPV1
antagonist capsazepine (1 µM) compared to 30 nM 5-HT alone (Fig. 2B, P = 0.038). In
other words, 5-HT-induced constriction was reduced by 39.14% by capsazepine (Fig. 2B).
The data indicated that TRPV1 is probably involved in 5-HT-induced facial artery
constriction. To examine the role of TRPV1 channel in 5-HT-induced facial artery
constriction, concentration response curves of 5-HT (1 nM-1 µM) have been done on
endothelium intact and endothelium denuded facial arteries from wild type mice and
endothelium intact facial arteries from TRPV1-KO mice. To rule out endothelial cells
involvement in 5-HT-induced facial artery constriction, we ran air bubbles slowly
through artery lumen to denude endothelial cells and found 5-HT (1 nM–1 µM)
constrictions between endothelium intact and endothelium denuded arteries are not
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significantly different (Fig. 2E, P > 0.05). EC50 of 5-HT in the endothelium denuded
artery is 85.6 nM, which is similar with EC50 of 5-HT in the endothelium intact artery
from the wild type mouse (Fig. 2E). These data suggested that endothelial cells are not
involved in 5-HT-induced facial artery constriction. The constriction caused by 5-HT (30
nM, 100 nM, 300 nM) in TRPV1-KO mice were significantly decreased compared to the
constriction in the facial artery from wild type, suggesting that TRPV1 is involved in 5HT-induced facial artery constriction (Fig. 2E, P = 0.004, P = 0.009, P = 0.01
respectively). However, 5-HT (1 µM)-induced constriction was not significantly different
between facial arteries from wild type mice and TRPV1-KO mice (Fig. 2E, P = 0.08).
This is probably due to multiple mechanisms participating when high concentration of 5HT is applied on the artery. But EC50 of 5-HT on the facial artery in TRPV1-KO is 202
nM, which is significantly greater than EC50 (86.8 nM) in the wild type mouse (Fig. 2E).
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Figure 2. 5-HT constricted mouse facial artery and blocking of TRPV1 channel
blunted 5-HT-induced facial artery constriction. A: Diameter recordings of an
isolated facial artery (FA) treated with PSS containing serotonin (30 nM), serotonin
(30 nM) + capsazepine (1 µM). Diameter changes by serotonin and serotonin +
capsazepin were expressed as percentage of diameter change over diameter before
drugs were added. B: Summary data obtained from A (mean ± S.E.M) (N = 5). C:
Cumulative concentration response curve of 5-HT obtained from endothelial cells
intact facial artery in wild type mouse pressurized to 80 mmHg ex vivo. D:
Cumulative concentration response curve of 5-HT obtained from endothelial cells
intact facial artery in TRPV1 knock out mouse. Arteries were exposed to PSS
containing each concentration of 5-HT and diameters were recorded when the
diameters were stable. E: Summary data obtained from C, D and 5-HT concentration
response curve from endothelial cells denuded facial artery from wild type mouse
(mean ± S.E.M) (N = 4). Each artery is from a different animal.*P<0.05
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PKC is involved in capsaicin (TRPV1 agonist)-induced facial artery constriction

During inflammation, TRPV1 is reported to be sensitized by protein kinase C (PKC) in
dorsal root ganglia (DRG) neurons, which leads to reduction in the threshold of the
temperature for TRPV1 activation to body temperature (Li et al., 2014). 5-HT2 receptor is
a Gq-protein-coupled receptor that activates phospholipase C (PLC) generating
diacylglycerol (DAG). DAG is a necessary component in activating PKC. Therefore, we
studied the TRPV1 and 5-HT2 receptor downstream signalling molecule PKC
relationship in artery constriction by studying PKC’s effect on capsaicin (TRPV1
agonist)-induced constriction. Vasoconstriction to capsaicin (100 nM) were examined in
the presence or absence of PKC inhibitor chelerythrine (1 µM) or PKC activator phorbol
12-myristate 13-acetate (PMA, 100 nM) on the facial artery from wild type mice.
Capsaicin (100 nM) constricted the mouse facial artery to 74.3 ± 1.14%. Percent of
constriction of the facial artery to capsaicin was reduced to 58.6 ± 4.89% in the presence
of PKC inhibitor chelerythrine (1 µM) compared to capsaicin alone 74.3 ± 1.14% (Fig.
3B, P = 0.048). Washing 30 min with PSS restored capsaicin constriction to previous
level 72.62 ± 3.59% (P = 0.62). There was a trend that percent of constriction of the
facial artery to capsaicin was slightly increased to 81.04 ± 4.93% in the presence of PKC
activator PMA (100 nM) compared to capsaicin alone 67.58 ± 3.14% without statistical
significance (Fig. 3B, P = 0.22). This lack of effect may be because PMA (100 nM) is a
potent PKC activator that saturates PKC activity prior to the addition of capsaicin. 5-HT2
receptor downstream signaling pathway involves PKC and PKC is involved in capsaicin38

induced facial artery constriction. Thus, these data indicated that 5-HT2 receptor is the
potential subtype in serotonin-induced facial artery constriction through opening of
TRPV1 channels.

A

B

Figure 3. Capsaicin constricted mouse facial artery and PKC is involved in
capsaicin-induced facial artery constriction. A: Diameter recordings of an isolated
facial artery (FA) treated with PSS containing capsaicin (100 nM), capsaicin (100
nM) + PKC inhibitor chelerythrine (1 µM), capsaicin (100 nM) + PKC activator
PMA (100 nM). Diameter changes by capsaicin, capsaicin + PKC inhibitor
chelerythrine and capsaicin + PKC activator PMA were expressed as percentage of
diameter change over diameter before drugs were added. B: Summary data obtained
from A (mean ± S.E.M) (N = 5). Each artery is from a different animal.*P<0.05
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5-HT-induced facial artery constriction is mediated mostly by activation of 5-HT1
and 5-HT2 receptors

We applied 5-HT1 or 5-HT2 receptor antagonists separately or in combination to
examine 5-HT (100 nM)-induced facial artery constriction. Applying 5-HT1 or 5-HT2
receptor subtype antagonists after serotonin constriction respectively to examine whether
5-HT1 and 5-HT2 receptors are involved in 5-HT-induced facial artery constriction. 5HT1 receptor antagonist GR55562 (1 µM) decreased the constriction caused by 100 nM
5-HT from 29.63 ± 2.15% to 10.08 ± 0.66% (Fig. 4B, P = 1.28 × 10- 4). 5-HT2 receptor
antagonist ritanserin (1 µM) decreased 100 nM 5-HT-induced facial artery constriction
from 29.5 ± 2.24% to 12.08 ± 0.82% (Fig. 4D, P = 3.35 × 10- 4). To study how much of
5-HT-induced facial artery constriction is caused by the activation of 5-HT1 and 5-HT2
receptors, we preincubated 1 µM GR55562 and 1 µM ritanserin to investigate the 100 nM
5-HT-induced facial artery constriciton. The data indicated that 92.4 % of 5-HT-induced
facial artery constriction is caused by the activation of 5-HT1 and 5-HT2 receptors (Fig.
4F, P = 0.001). This enabled us to use 5-HT plus 5-HT1 receptor antagonist GR55562 to
activate 5-HT2 receptor and 5-HT + 5-HT2 receptor antagonist ritanserin to activate 5HT1 receptor in the facial artery constriction in the subsequent experiments. These data
demonstrated that both 5-HT1 and 5-HT2 receptors are involved in 5-HT-induced facial
artery constriction with different contributions.
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Figure 4. Both 5-HT1 and 5-HT2 receptor antagonists can partly decrease 5-HTinduced facial artery constriction. 5-HT-induced facial artery constriction is
mediated mostly by activation of 5-HT1 and 5-HT2 receptors. A: Diameter recordings
of an isolated facial artery (FA) treated with PSS containing 5-HT (100 nM), 5-HT (100
nM) + GR55562 (1 µM). Diameter changes by 5-HT and 5-HT + GR55562 were
expressed as percentage of diameter change over the diameter before drugs were added.
B: Summary data obtained from A (mean ± S.E.M) (N = 4). C: Diameter recordings of an
isolated facial artery (FA) treated with PSS containing 5-HT (100 nM), 5-HT (100 nM) +
ritanserin (1 µM). Diameter changes by 5-HT and 5-HT + ritanserin were expressed as
percentage of diameter change over the diameter before drugs were added. D: Summary
data obtained from C (mean ± S.E.M) (N = 4). E: Diameter recordings of an isolated
facial artery (FA) treated with PSS containing GR55562 (1 µM) + ritanserin (1 µM),
GR55562 (1 µM) + ritanserin (1 µM) + 5-HT (100 nM). Diameter changes by GR55562 +
ritanserin and GR55562 + ritanserin + 5-HT treatments were expressed as percentage of
diameter change over the diameter before drugs were added. F: Summary data obtained
from E (mean ± S.E.M) (N = 4). Each artery is from a different animal.*P<0.05

5-HT2 but not 5-HT1 receptor is involved in 5-HT-induced facial artery constriction
via TRPV1 activation

We next examined the relative role of TRPV1 channels in facial artery constrictions
induced by 5HT1 and 5HT2 receptor activation. From Fig. 3, PKC is involved in
capsaicin-induced constriction. Thus we speculated 5-HT2 is the potential 5-HT receptor
subtype in 5-HT-induced constriction via opening of TRPV1 channels. We used 5-HT1
receptor agonist (sumatriptan, 10 µM) or 5-HT2 receptor agonist (DOI, 1 µM) in the
presence or absence TRPV1 antagonist capsazepine to examine TRPV1’s involvement in
5-HT1 receptor- or 5-HT2 receptor-induced constriction to further demonstrate that 5-HT2
but not 5-HT1 receptor is involved in the TRPV1 mechanism in the facial artery
constriciton. Sumatriptan (5-HT1 receptor agonist, 10 µM) constricted mice facial arteries
to 18.35 ± 1.74%. Percent of constriction of the facial artery with 10 µM sumatriptan was
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not reduced significantly in the presence of TRPV1 antagonist 1 µM capsazepine (14.1 ±
1.52%) compared to sumatriptan alone (Fig. 5B, P = 0.9). TRPV1 is not involved in
sumatriptan-induced facial artery constriction. To further elucidate the role of TRPV1 in
5-HT receptor subtype-induced constriction in the facial artery, vasoconstriction to 100
nM 5-HT + 1 µM GR55562 (activating 5-HT2 receptor) was examined in the absence and
presence of TRPV1 antagonist capsazepine (1 µM) using facial arteries obtained from
wild type mice. Similarly, we used 5-HT (100 nM) + 1 µM ritanserin (5-HT2 receptor
antagonist) to activate 5-HT1 receptor in the facial artery as control. The results
demonstrated that 5-HT (100 nM) + GR55562 (1 µM) (5-HT2 receptor activation) caused
12.63 ± 0.41% constriction and 1 µM capsazepine decreased this constriction to 6.83 ±
0.46% significantly (Fig. 5D, P = 0.002). Washing 30 min with PSS restored 5-HT +
GR55562-induced constriction to previous level 14.68 ± 1.33% (P = 0.25). However, 1
µM capsazepine cannot blunt constriction induced by 5-HT (100 nM) + ritanserin (1 µM)
(5-HT1 receptor activation) in the facial artery from the wild type mouse significantly
(Fig. 5F, P = 0.77) indicating that TRPV1 is not involved in 5-HT1 receptor activationinduced facial artery constriction. TRPV1 inhibition by capsazepine can significantly
blunt 5-HT-induced 5-HT2 receptor-mediated facial artery constriction but not 5-HT1
receptor-mediated facial artery constriction. These data demonstrated that 5-HT2 receptor
but not 5-HT1 receptor is involved in 5-HT-induced facial artery constriction through
opening of TRPV1 channels.
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Figure 5. 5-HT2 but not 5-HT1 receptor is involved in 5-HT-induced facial artery
constriction via TRPV1 activation. A: Diameter recordings of an isolated facial artery
(FA) treated with PSS containing sumatriptan (10 µM), sumatriptan (10 µM) +
capsazepine (1 µM). Diameter changes by sumatriptan and sumatriptan + capsazepine
were expressed as percentage of diameter change over the diameter before drugs were
added. B: Summary data obtained from A (mean ± S.E.M) (N = 4). C: Diameter
recordings of an isolated facial artery (FA) treated with PSS containing 5-HT (100 nM)
+ GR55562 (1 µM), 5-HT (100 nM) + GR55562 (1 µM) + capsazepine (1 µM).
Diameter changes by 5-HT + GR55562 and 5-HT + GR55562 + capsazepine were
expressed as percentage of diameter change over the diameter before drugs were added.
D: Summary data obtained from C (mean ± S.E.M) (N = 4). E: Diameter recordings of
an isolated facial artery (FA) treated with PSS containing 5-HT (100 nM) + ritanserin (1
µM), 5-HT (100 nM) + ritanserin (1 µM) + capsazepine (1 µM). Diameter changes by 5HT + ritanserin and 5-HT + ritanserin + capsazepine were expressed as percentage of
diameter change over the diameter before drugs were added. F: Summary data obtained
from E (mean ± S.E.M) (N = 4). Each artery is from a different animal.*P<0.05

Possible PKC involvement in 5-HT-induced facial artery constriction.

PKC is the downstream molecule for 5-HT2 receptor activation and may be involved in
5-HT-induced facial artery constriction if 5-HT binds with 5-HT2 receptor. There was a
trend that percent of constriction of the facial artery with 30 nM 5-HT was decreased to
24.56 ± 4.81% in the presence of PKC inhibitor chelerythrine (1 µM) compared to 5-HT
alone (36.46 ± 2.70%) without statistical significance (Fig. 6B, P = 0.32). Washing 30
min with PSS restored 5-HT-induced constriction to previous level 31.06 ± 5.07% (P =
0.55). Fig. 6B showed a trend that percent of constriction in the facial artery with 30 nM
5-HT was increased to 38.3 ± 6.89% in the presence of PKC activator PMA (100 nM)
compared to 5-HT alone (31.06 ± 5.07%) without statistical significance (Fig. 6B P =
0.41). This may be due to the fact that 5-HT has multiple intracellular second messengers
that mediate artery constriction besides PKC. PKC’s contribution is not strong enough to
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influence 30 nM 5-HT constriction and PKC’s role is taken over by other molecules after
PKC activity is changed. Since PKC (activated upon 5-HT2 receptor activation) activator
and inhibitor had the trend of increasing and decreasing 5-HT-induced facial artery
constriction respectively, we conclude that 5-HT2 receptor activation may be involved in
5-HT-induced facial artery constriction.
A

B
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Figure 6. PKC is probably involved in 5-HT-induced facial artery constriction. A:
Diameter recordings of an isolated facial artery (FA) treated with PSS containing 5-HT
(30 nM), 5-HT (30 nM) + chelerythrine (1 µM), 5-HT (30 nM) + PMA (100 nM).
Diameter changes by 5-HT, 5-HT + chelerythrine and 5-HT + PMA were expressed as
percentage of diameter change over the diameter before drugs were added. B: Summary
data obtained from A (mean ± S.E.M) (N = 5). Each artery is from a different
animal.*P<0.05

L-type-voltage-dependent Ca2+ channel (L-VDCC) is involved in 5-HT-induced
facial artery constriction.
Since TRPV1 is a non selective cation channel that has high permeability for Ca2+, we
studied L-type-voltage-dependent Ca2+ channel involvement in 5-HT-induced facial
artery constriction to provide further evidence that Ca2+ entry channel, for example
TRPV1, is involved in 5-HT constriction. 5-HT (30 nM) constricted mouse facial artery
to 32.12 ± 2.68% (Fig. 7B). The L-type-VDCC inhibitor nifedipine (1 µM) partly
decreased facial artery constriction caused by 30 nM serotonin from 32.12 ± 2.68% to
12.36 ± 2.57% significantly (Fig. 7B, P = 0.001). In other words, 5-HT-induced
constriction was decreased by 61.5% by nifedipine. Percent of constriction in the facial
artery with 30 nM 5-HT was reduced significantly to 8.26 ± 1.19% in the presence of
TRPV1 antagonist capsazepine (1 µM) and nifedipine (1 µM) compared to 30 nM 5-HT
alone (Fig. 7B, P = 4.36 × 10-5). These data suggested that L-type-voltage-dependent
Ca2+ channel (L-VDCC) is involved in 5-HT-induced facial artery constriction. However,
constriction in the presence of 5-HT + capsazepine + nifedipine (8.26 ± 1.19%) was not
significantly reduced compared with 5-HT + nifedipine constriction (12.36 ± 2.57%) (Fig.
7B, P = 0.75), although we saw a greater reduction (76.3%) of 5-HT constriction by
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nifedipine + capsazepine compared with by nifedipine alone (61.5%) (Fig. 7B). This may
be due to the possibility that after L-VDCCs are blocked, the contribution of TRPV1 is
masked by other cellular pathways. In other words, TRPV1’s involvement in 5-HTinduced constriction is weakened when L-VDCC is blocked.

A

B

Figure 7. Blocking of L-VDCC blunted 5-HT-induced facial artery constriction. A:
Diameter recordings of an isolated facial artery (FA) treated with PSS containing
serotonin (30 nM), serotonin (30 nM) + nifedipine (1 µM) and serotonin (30 nM) +
nifedipine (1 µM) + capsazepine (1 µM). Diameter changes by serotonin, serotonin +
nifedipine and serotonin + nifedipine + capsazepine were expressed as percentage of
diameter change over the diameter before drugs were added. B: Summary data obtained
from A (mean ± S.E.M) (N = 5). Each artery is from a different animal.*P<0.05
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2.4. Conclusions and Discussion

Functional TRPV1 was expressed in the mouse facial artery and activation of TRPV1
by capsaicin caused the artery constriction (unpublished observations by the Wellman
laboratory). In the present study, 5-HT, an endogenous vasoactive monoamine, was
found to cause the mouse facial artery constriction. In the peripheral system, 5-HT is
mostly stored in platelets (Mercado and Kilic, 2010). When activated platelets bind with
a clot, platelets release 5-HT and 5-HT serves as a vasoconstrictor and helps to regulate
hemostasis and blood clotting (Ziu et al., 2012). Tight regulation of cephalic blood
circulation is critical under normal physiological conditions, and dysregulation of blood
flow to the head occurs in pathophysiological situations such as stroke and migraine
headache. External carotid artery mainly branches into the superficial temporal artery,
maxillary artery and facial artery. The facial artery (external maxillary artery in older
texts) supplies blood of the superficial face which is important in the head hemodynamic
regulation. Additionally, if arteries in external carotid artery territory are constricted, the
blood will be shunted to the internal carotid artery which has no TRPV1 expression
(unpublished observations by the Wellman laboratory) providing intracranial blood. The
increase of intracranial blood is beneficial to many CNS diseases that are due to shortage
of brain blood supply. Thus studying how TRPV1 channel activation-induced artery
constriction is regulated by endogenous substance such as 5-HT in the facial artery is
important in understanding TRPV1’s vasoactive effect in the vasculature. Our findings
suggested that inhibition of the TRPV1 channel blunted serotonin-induced mouse facial
artery constriction. We found PKC was involved in TRPV1 activation-induced facial
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artery constriction. 5-HT-induced facial artery constriction was caused mainly by 5-HT1
and 5-HT2 receptors activation. Capsazepine can not blunt sumatriptan (5-HT1 receptor
agonist)-induced facial artery constriction indicating that TRPV1 is not involved in
sumatriptan-induced facial artery constriction. We used 5-HT + 5-HT1 receptor
antagonist or 5-HT2 receptor antagonist to activate 5-HT2 receptor or 5-HT1 receptor
respectively. Capsazepine can blunt constriction induced by 5-HT + 5-HT1 receptor
antagonist but not constriction induced by 5-HT + 5-HT2 receptor antagonist. DOI (5HT2 receptor agonist) did not constrict the facial artery (data not shown). DOI is a partial
agonist for 5-HT2A receptor (EC50 = 0.03 µM), which constricted the endothelial denuded
mouse aorta, dog internal carotid artery and rat mesenteric artery (Centurion et al., 2001;
Fernandez et al., 2000; McKune and Watts, 2001). DOI has 30 times higher affinity for
5-HT (2A) receptor than 5-HT (2B) receptor (Nelson et al., 1999). 5-HT (2B) receptors
agonists produced concentration-dependent constriction of mouse aorta (Nelson et al.,
2012). Thus the facial artery constriction is possibly through both 5-HT (2A) and 5-HT
(2B) receptors activation and 5-HT (2B) receptor contributes more to the constriction
than 5-HT (2A) receptor. Therefore 1 µM DOI is not potent enough to cause constriciton
in the facial artery. This work represents the first study examining TRPV1 potential
involvement in 5-HT-induced 5-HT2 receptor-mediated facial artery constriction.

Capsaicin (100 nM) constricted the facial artery from C57BL/6J mouse indicating
functional TRPV1 channel is expressed in the facial artery (Fig. 3A). TRPV1 is a cation
channel on the cell membrane, which has a high permeability for Ca2+. Ca2+-calmodulindependent activation of myosin light chain kinase (MLCK) is a requisite step for
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myogenic constriction (Raina et al., 2009). 5-HT constricts arteries by inhibiting Kv
channels via 5-HT2A receptor and Src tyrosine kinase pathway (Sung et al., 2013). Kv
channel inhibition induces cell membrane depolarization (Waldron and Cole, 1999).
TRPV1 channel opening induces Ca2+ influx, which leads to membrane depolarization as
well (Boillat et al., 2014). Since both 5-HT and capsaicin constricted the mouse facial
artery, 5-HT constriction on the facial artery is probably via opening of TRPV1 channels.
During inflammation, TRPV1 is reported to be sensitized by protein kinase C (PKC) in
dorsal root ganglia (DRG) neurons, which leads to reduction in the threshold of the
temperature for TRPV1 activation to body temperature (Sugimoto et al., 2013). PKC
activation results in direct phosphorylation of TRPV1(Li et al., 2014). Our lab found
PKC is involved in capsaicin-induced mouse middle meningeal artery constriction and is
a necessary component in sustaining capsaicin constriction on the artery (unpublished
observations by the Wellman laboratory). By using in vitro phosphorylation and protein
sequencing techniques, people identified several potential PKC phosphorylation sites on
TRPV1 intracellular domains (Numazaki et al., 2002). Functional studies suggested that
activation of TRPV1 by phorbol esters is phosphorylation-independent but modulated by
PKC-mediated phosphorylation (Bhave et al., 2003). 5-HT exerts vasoconstrictive and
mitogenic effects and both of them are dependent on an increase of cytosolic [Ca2+]i in
pulmonary artery smooth muscle cells (PASMCs) (Goyal et al., 2011). Stimulation of 5HT receptor may activate a novel type of choleratoxin-sensitive G-protein and
subsequent PKC, and the phosphorylation of voltage-dependent Ca2+ channels by PKC
may result in the increase in Ca2+ entry and subsequent Ca2+-activated K+ current
(Kawasaki et al., 2007). Thus, we supposed PKC links the 5-HT receptor and the TRPV1
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channel, which leads to our hypothesis of TRPV1’s involvement in 5-HT-induced
constriction. Although we found PKC inhibitor chelerythrine blunted capsaicin-induced
constriction, However, we can only see the trend of PKC activator (PMA)’s potentiating
effect on capsaicin-induced constriction without statistical significance. We used power
calculation to calculate the possibility of getting P < 0.05 significance and found with N
= 5 (repetitive experiments times), the possibility of getting statistical significance is 70%
between capsaicin and capsaicin + PMA. Thus, to increase the power of the statistical
analysis, the observed trend may turn into a significant difference (P ˂ 0.05). PKC is the
downstream signalling molecule of 5-HT2 receptor activation (Blank et al., 1996). 5-HT
augmented voltage-dependent Ca2+ channels currents in Aplysia ganglia (Kawasaki et al.,
2007), which enables us to propose the TRPV1 involvement in 5-HT-induced facial
artery constriction acting as a Ca2+ entry channel. Additionally, there is evidence
demonstrating direct correlation between 5-HT receptor and TRPV1 channel. Facilitation
of TRPV1 by metabotropic 5-HT receptor activation may contribute to hypersensitivity
of primary afferent neurons in Irritable Bowel Syndrome patients (Sugiuar et al., 2004).

Endothelial cells play a significant role in vascular tone, and have been demonstrated to
be involved in many diseases (Veerasamy et al., 2015). Serotonin stimulates release of
vasodilator substances such as nitric oxide by activating 5HT1B and 5-HT2B receptors on
endothelial cells to cause artery dilation (Ishida et al., 1998). We used a series of different
5-HT concentrations (1 nM-1 µM) to examine the constrictions in endothelial cells
denuded and endothelial cells intact facial arteries. There was no significant difference
between those two groups, indicating that endothelial cells are not involved in 5-HT52

induced facial artery constriction. Our lab used TRPV1-tdTomato reporter mice to
examine the TRPV1 channel of the facial artery and found that TRPV1 is only expressed
in smooth muscle cells of the facial artery but not in endothelial cells or perivascular
nerves (unpublished observations by the Wellman laboratory). However, capsaicin is
reported to increase nitric oxide (NO) metabolites production in human vein endothelial
cells (ECs) (Lo et al., 2003). In vivo and in vitro experimental evidence demonstrated
that long-term activation of TRPV1 can actually increase the phosphorylated levels of
protein kinase A (PKA) and endothelial NO synthase (eNOS) in mesenteric arteries and
plasma levels of NO metabolites. Phosphorylated eNOS augmented endotheliumdependent relaxation and lower arterial pressure in hypertensive rats (Yang et al., 2010).
Vasodilation induced by electrical field stimulation (EFS) of perivascular sensory nerves
is mediated by the TRPV1 via releasing of sensory neurotransmitters (CGRP) in wild
type mice (Wang et al., 2006). Thus TRPV1-mediated artery dilation is mainly mediated
by two pathways: Activation of TRPV1 in endothelial cells causing eNOS activation and
NO increase, and activation of TRPV1 in perivascular nerves leading to CGRP release.
Both NO and CGRP dilate the artery. In the facial artery, our data indicate that TRPV1
activation is associated with vasoconstriction rather than vasodilation.

5-HT-evoked constriction of human coronary arteries is mostly mediated via activation
of both 5-HT1B and 5-HT2A receptors (Nilsson et al., 1999). Sumatriptan or eletriptan
produced vasocontriction in the common carotid artery (CCA) by stimulating 5HT1B
receptors in rabbits (Akin et al., 2002). However, ketanserin (5-HT2A receptor antagonist)
inhibited 5-HT-induced constriction of canine pulmonary arteries, indicating that 5-HT2A
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receptor activation is important to arterial constriction (Wilson et al., 2005). Thus, we
focused on 5-HT1 and 5-HT2 receptor subtypes when studying 5-HT-induced facial artery
constriction. Studies showed that 80-86% of the maximum 5-HT-evoked constriction of
the human temporal artery is mediated through 5-HT2A receptors, the remainder through
5-HT1-like-receptors, regardless of whether or not endothelium is functional (Verheggen
et al., 1996). However, our data indicated that 5-HT1 and 5-HT2 receptor play an even
role (around 34 % and 41 % respectively) in 5-HT-induced facial artery constriction.
Based on the different ratios of 5-HT1 and 5-HT2 receptor involvement in 5-HT-induced
constriction between the temporal artery and facial artery, thus, although temporal artery
and facial artery are all branches from the external carotid artery, 5-HT1 and 5-HT2
receptor’s involvement in 5-HT-induced arteries constriction is different. Our data
suggested that 5-HT-induced facial artery constriction is mostly mediated by 5-HT1 and
5-HT2 receptors activation. Either 5-HT1 or 5-HT2 antagonist can partly decrease
constriction caused by 100 nM 5-HT (Fig. 4B, D). By preincubation of both 5-HT1 and 5HT2 receptors antagonists, 5-HT constriction on the facial artery was mostly reversed
although there was still little constriction that is probably caused by other mechanisms
(Fig. 4F). Some studies demonstrated that there are other receptors involved in 5-HTinduced artery cosntriction. At low concentrations of 5-HT (≤ 10-5 M), 5-HT-induced dog
mesenteric artery constriction is mediated by 5-HT2 receptors, but with higher
concentration, it is mediated by α-adrenergic receptors (Shimamoto et al., 1994). This
indicates that different 5-HT concentrations can act on different receptors besides 5-HT
receptors, which makes studying 5-HT vasoactive role on the artery more complicated.
Downstream signalling molecules that are involved in 5-HT-induced facial artery
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constriction through 5-HT1 and 5-HT2 receptor activation have not been studied either. 5HT constricts rat mesenteric artery by inhibiting 4-aminopyridine-sensitive Kv channels
via the 5-HT (2A) receptor (Sung et al., 2013). Kv channel inhibition leads to smooth
muscle cell membrane depolarization and L-VDCC opening (Sung et al., 2013). L-VDCC
is a major Ca2+ entry channel to induce smooth muscle contraction (Amberg and Navedo,
2013). We found blocking of TRPV1 channels and L-VDCC blunted 5-HT-induced facial
artery constriction, indicating TRPV1 may represent an additional Ca2+ entry pathway.

PKC is involved in capsaicin-induced facial artery constriction (Fig. 3). Therefore, we
examined PKC’s involvement in 5-HT-induced constriction to determine potential 5-HT
receptor subtype that is involved in 5-HT-induced constriction via opening of TRPV1
channels. However, we can only see the trend of PKC’s involvement in 5-HT-induced
constriction without statistical significance. We used power calculation to calculate the
possibility of getting P < 0.05 significance and found with N = 5 (repetitive experiments
times), the possibility of getting statistical significance are 70% between 5-HT and 5-HT
+ chelerythrine, 40% between 5-HT and 5-HT + PMA. If we increase the sample number,
the trend may turn to significance (P ˂ 0.05). Our finding suggests serotonin binds with
5-HT2 receptor leading to PKC activation. PKC activates TRPV1 channel causing Ca2+
entry leading to smooth muscle cell contraction in the facial artery. Intracellular Ca2+ and
Na+ increase causes cell membrane depolarization and subsequently opening of L-VDCC
channels that leads to more constriction. However, capsazepine cannot decrease 5-HT +
nifedipine induced constriction significantly (Fig. 7). There was a trend of capsazepine’s
reduction on 5-HT + nifedipine constriction because nifedipine blunted 5-HT constriction
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by 61.5% and capsazepine + nifedipine blunted 5-HT constriction by 76.3% (Fig. 7).
Using power calculation, we found with 5 repetitive experiments, power possiblity to get
statistical significance (P < 0.05) is 50%. Thus more repetitive experiments are required
to get statistical significance. After both L-VDCC and TRPV1 channels were blocked,
there was still around 8% 5-HT constriction left. Therefore, besides Kv channel inhibition,
L-VDCC activation and TRPV1 activation, there are other signalling pathways that are
involved in 5-HT-induced artery constriction. For example, by activating rho/rho kinase
pathway, c-Src pathway or releasing of IP3 to cause sarcoplasmic reticulum Ca2+ release,
5-HT causes arteries constriction. Serotonin-induced contrictions are mediated by 5HT2A
receptors on vascular smooth muscle, which activates the rho/rho kinase pathway to
regulate phosphorylation of myosin light chain phosphatase and myosin light chain
(Dreja et al., 2002; Nuno et al., 2007). Inhibition of c-Src tyrosine kinase activity prior to
constriction resulted in approximately 90 - 99% inhibition of constrictions induced by 5HT or 5-HT (2) recptor agonist in rats aortic arteries (Lu et al., 2008). 5-HT-mediated
constriction in canine pulmonary arteries is reliant on release of IP3 but not ryanodinesensitive Ca2+ stores and cytosolic [Ca2+] increases were partially inhibited by nisoldipine,
a voltage-dependent Ca2+ channel blocker (Wilson et al., 2005). Ca2+ entry upon exposure
to 5-HT through L-VDCC versus TRPV1 channels will require further studies. But in
addition to L-VDCC opening, 5-HT1 receptor activation, and 5-HT2 receptor indirectly
activating TRPV1, whether there are other mechanisms (for example by activating other
Ca2+ entry channels) are involved in 5-HT-induced facial artery constriction will require
further studies.
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The proposed pathway showing the contribution of TRPV1 to 5-HT-induced mouse
facial artery constriction is described as below (Fig. 8).

Figure 8. : The Scheme of TRPV1 involvement in 5-HT-induced facial artery
constriction.
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2.5. Future directions

In the present study, we found activation of TRPV1 channel contributes to 5-HTinduced 5-HT2 receptor-mediated mouse facial artery constriction. Our lab used TRPV1tdTomato mouse demonstrated TRPV1 expression in external carotid artery territory.
However, we did not find TRPV1 expression in internal carotid artery including cerebral
artery or common carotid artery (unpublished observations by Wellman laboratory).
Since TRPV1 channel is a cation channel permeable to Ca2+ and Na+ causing cell
membrane depolarization (Boillat et al., 2014). Thus the TRPV1 channel opening
contributes to two pathways that lead to smooth muscle contraction. One is by increasing
cytoplasmic Ca2+, which binds with calmodulin to activate myosin light chain kinase
(Webb, 2003); the other one is the cation entry inducing cell membrane depolarization
and L-VDCC opening to cause more Ca2+ entry and constriction. Since the cerebral artery
is TRPV1 negative, it has less cation influx compared with the facial artery that has
TRPV1 expression when being exposed to vasoactive G-protein-coupled receptors
agonists for instance 5-HT. 5-HT constricts cerebral arteries via activation of 5-HT (1B)
and 5-HT (2A) receptors (Kovacs et al., 2012). Further study is required to compare
concentration response curves of 5-HT on the facial artery and cerebral artery. Without
TRPV1 channel involvement, cerebral artery constriction to 5-HT will be smaller than
the facial artery constriction.

Using G-CaMP5 (green fluorescent protein, Ca2+-sensitive) mice, we examined Ca2+
image in the facial artery with addition of α-adrenergic receptor (Gq–protein–coupled
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receptor, GPCR) agonist phenylephrine and capsazepine. We found capsazepine
significantly blunted phenylephrine-induced Ca2+ increase in the facial artery and caused
artery dilation after phenylephrine-induced constriction (unpublished observations by the
Wellman laboratory). It suggests the GPCR–Gq-PLC–PKC–TRPV1 signaling in
mediating phenylephrine-induced facial artery constriction. Similarly, since 5-HT (2)
receptor is also a Gq–protein–coupled receptor, blocking of TRPV1 channel may reduce
5-HT-induced Ca2+ increase in the facial artery. Using G-CaMP5 mice, we will apply 5HT and capsazepine to examine TRPV1’s involvement in 5-HT-induced Ca2+ increase
and constriction in the facial artery.

Thromboxane, angiotensin II and endothelin are endogenous vasoconstrictors that bind
with GPCR. Thromboxane is an endogenous vasoconstrictor and induces rabbit
pulmonary artery constriction and PKC inhibitors blunt thromboxane-induced
constriction (Murtha et al., 1999). Thromboxane A2 is one of the major thromboxanes.
The thromboxane A2 receptor is a Gq–protein–coupled receptor that activates PLC-β
which mediates the conversion of phosphatidylinositol 4,5-bisphosphate (PIP2) to IP3 and
DAG. The second messenger IP3 serves to release intracellular calcium stores and DAG
activates protein kinase C (Ting et al., 2012). PKC can activate TRPV1 causing Ca2+
entry. Thus, we suppose that the activation of TRPV1 constributes to thromboxaneinduced facial artery constriction. Angiotensin II (AngII), the major bioactive peptide of
the renin–angiotensin system, plays a critical role in controlling cardiovascular
homoeostasis (Li et al., 2012). AngII type-1 receptor (AT1) has been shown to be
predominantly expressed in cardiovascular cells, such as vascular smooth muscle cells
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mediating artery constriction, for example, skeletal muscle artery, renal artery, coronary
artery, aortic artery and cerebral artery, etc (Czikora et al., 2015; Guo et al., 2013; Huang
et al., 1994; Li et al., 2016). The AT1 receptor interacts with multiple heterotrimeric G–
proteins including Gq, which activates PKC (Higuchi et al., 2007) which potentially leads
to TRPV1 activation. Thus, TRPV1 is probably involved in AngII-induced artery
constriction. Similarly, endothelin constricts a variety of arteries, such as, pulmonary
artery, coronary artery, cerebral artery and mesenteric artery (Assenzio et al., 2015;
Compeer et al., 2013; Liang et al., 2012; Skovsted et al., 2015). In human coronary
microvasculature, the constriction response to endothelin-1 is in part through the
activation of endothelin-A receptor and PKCα (Feng et al., 2010). Endothelin, acting
through endothelin-B receptors, induces mechanical hypernociception in the rat hindpaw
via cAMP formation and activation of the PKC-dependent phosphorylation cascade (da
Cunha et al., 2004). Thus endothelin also has the potential of sensitizing TRPV1 through
PKC activation. We propose that activation of TRPV1 contributes to endothelin-induced
artery constriction.
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